Executive dysfunction in treated phenylketonuric patients

European Child and Adolescent Psychiatry

Volumn 18, Issue 6, 2009, Pages 360-368

  Azadi, Bahare ^a,b   Seddigh, Arshia ^a   Tehrani Doost, Mehdi ^b,c   Alaghband Rad, Javad ^c,d   Ashrafi, Mahmoud Reza ^e  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b INSTITUTE FOR COGNITIVE SCIENCE STUDIES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d DALHOUSIE UNIVERSITY   (Canada)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Early treated phenylketonuria; Executive function; Neuropsychology; Serum phenylalanine

Indexed keywords

PHENYLALANINE;

ADOLESCENT; ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FUNCTIONAL STATUS; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; PERFORMANCE; PHENYLKETONURIA; PRESCHOOL CHILD; SCHOOL CHILD; TASK PERFORMANCE;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; COGNITION DISORDERS; FEMALE; HUMANS; INTELLIGENCE; MALE; NEUROPSYCHOLOGICAL TESTS; PHENYLKETONURIAS; PROBLEM SOLVING; PSYCHOMETRICS; REACTION TIME; REFERENCE VALUES; SOCIAL BEHAVIOR DISORDERS; YOUNG ADULT;

EID: 67349218403     PISSN: 10188827     EISSN: 1435165X     Source Type: Journal    
DOI: 10.1007/s00787-009-0738-8     Document Type: Article

References (34)

1. GL Arnold CJ Vladutiu CC Orlowski EM Blakely J DeLuca 2004 Prevalence of stimulant use for attentional dysfunction in children with phenylketonuria J Inherit Metab Dis 27 2 137 143 (Pubitemid 38756329)
2. S Baieli L Pavone C Meli A Fiumara M Coleman 2003 Autism and phenylketonuria J Autism Dev Disord 33 2 201 204 (Pubitemid 36505298)
3. MC Davidson D Amso LC Anderson A Diamond 2006 Development of cognitive control and executive functions from 4 to 13 years: evidence from manipulations of memory, inhibition, and task switching Neuropsychologia 44 11 2037 2078 (Pubitemid 43993998)
4. A Diamond 1994 Phenylalanine levels of 6-10 mg/dl may not be as benign as once thought Acta Paediatr 83 Suppl 407 89 91
5. A Diamond MB Prevor G Callender D Druin 1997 Prefrontal cortex cognitive deficits in children treated early and continuously for PKU Monogr Soc Res Child Dev 62 4 1 208 (Pubitemid 127459627)
6. Diamond A (2001) A model system for studying the role of dopamine in the prefrontal cortex during early development in humans: early and continuously treated phenylketonuria. In: Handbook of developmental cognitive neuroscience. MIT Press, Cambridge, pp 433-472
7. K DeRoche M Welsh 2008 Twenty-five years of research on neurocognitive outcomes in early-treated phenylketonuria: intelligence and executive function Dev Neuropsychol 33 4 474 504
8. R Feldmann J Denecke M Pietsch M Grenzebach J Weglage 2002 Phenylketonuria: no specific frontal lobe-dependent neuropsychological deficits of early-treated patients in comparison to diabetic patients Pediatr Res 51 761 765 (Pubitemid 34547342)
9. I Følling 1994 The discovery of phenylketonuria Acta Pediatr Suppl 407 4 10
10. P Griffiths R Campbell P Robinson 1998 Executive function in treated phenylketonuria as measured by the one-back and two-back versions of the continuous performance test J Inherit Metab Dis 21 125 135 (Pubitemid 28156172)
11. F Happé R Booth R Charlton C Hughes 2006 Executive function deficits in autism spectrum disorders and attention-deficit/hyperactivity disorder: examining profiles across domains and ages Brain Cogn 61 1 25 39
12. SR Hooper D Hatton J Sideris K Sullivan J Hammer J Schaaf P Mirrett PA Ornstein DP Bailey Jr 2008 Executive functions in young males with fragile X syndrome in comparison to mental age-matched controls: baseline findings from a longitudinal study Neuropsychology 22 1 36 47
13. Koch R, Burton B, Coldwell J (2000) A 15-year follow-up report on participants in the collaborative study of children treated for Phenylketonuria (PKUCS 1967-1984): paper presented at the consensus development conference on phenylketonuria (PKU): screening and management. National Institutes of Health, Bethesda
14. J Koochmeshgi A Bagher SM Hosseini Mazinani 2002 Incidence of phenylketonuria in Iran estimated from consanguineous marriages J Inherit Metab Dis 25 80 81 (Pubitemid 34303231)
15. V Leuzzi M Pansini E Sechi F Chiarotti CL Carducci G Levi I Antonozzi 2004 Executive function impairment in early-treated PKU subjects with normal mental development J Inherit Metab Dis 27 115 125 (Pubitemid 38756327)
16. M Luciana J Sullivan OA Nelson 2001 Associations between phenylalanine to tyrosine ratios and performance on tests of neuropsychological function in adolescents treated early and continuously for phenylketonuria Child Dev 71 1637 1652 (Pubitemid 33602780)
17. MM Mazzocco AM Nord WV Doornick CL Greene CG Kovar BF Pennington 1994 Cognitive development among children with early-treated phenylketonuria Dev Neuropsychol 10 133 151
18. CM tmp McKean 1972 The effects of high phenylalanine concentrations on serotonin and catecholamine metabolism in the human brain Brain Res 47 469 476
19. LP Miller WM Pardridge LD Braun WH Oldendorf 1985 Kinetic constants for blood-brain barrier amino acid transport in conscious rats J Neurochem 45 1427 1432 (Pubitemid 16252580)
20. LJ Porrino PS Goldman-Rakic 1982 Brainstem innervation of prefrontal and anterior cingulate cortex in the rhesus monkey revealed by retrograde transport of HRP J Comp Neurol 205 63 76 (Pubitemid 12192328)
21. Rezvani I (2000) Defects in metabolism of aminoacids-phenylalanine. Nelson textbook of pediatrics, 16th edn. Philadelphia, PA: W.B. Saunders Company, pp 329-333
22. MD Ris SE William MM Hunt HK Berry N Leslie 1994 Early- treated phenylketonuria: adult neuropsychologic outcome J Pediatr 124 388 392 (Pubitemid 24094448)
23. E Schmidt A Rupp P Burgard J Pietz J Weglage L Sonneville 1994 Sustained attention in adult phenylketonuria: the influence of the concurrent phenylalanine-blood-level J Clin Exp Neuropsychol 16 5 681 688 (Pubitemid 24331907)
24. Scriver CR, Kaufman S, Eisensmith RC, Woo SLCL (1995) The hyperphenylalaninemias. In: Scriver CR, Baudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 7th edn. McGraw-Hill, New York, pp 1015-1075
25. Scriver CR, Kaufman S (2000) The hyperphenylalaninemias: phenylalanine hydroxylase deficiency. In: Scriver CR, Baudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 9th edn. McGraw-Hill, New York, pp 1015-1037
26. Seddigh A, Azadi B, Ebrahimi M, Ghafarizadeh A, Koochmeshgi J, Hosseini-Mazinani SM (2001). Prevalence of hyperphenylalaninemia in the Iranian institutionalized developmentally delayed. J Inherit Metab Dis July 24 (suppl. 1)
27. T Shallice 1982 Specific impairments of planning Philos Trans R Soc Lond Ser B 298 199 209
28. NBA Stemerdink MW Molen AF Kalverboer JJ Vander Meere J Huisman LW De Jong FME Slijper PH Verkerk FJ Van Spronsen 1999 Prefrontal dysfunction in early and continuously treated phenylketonuria Dev Neuropsychol 16 1 29 57 (Pubitemid 29377263)
29. NB Stemerdink 2000 Comments on neuropsychological approaches to treatment policy issues in phenylketonuria Eur J Pediatr 159 Suppl 2 S82 S86
30. JR Stroop 1935 Studies of interference in serial verbal reactions J Exp Psychol 18 622 643
31. MC Welsh BF Pennington S Ozonoff B Rouse ERB tmp McCabe 1990 Neuropsychology of early-treated phenylketonuria: specific executive function deficits Child Dev 61 1697 1713
32. Welsh M, Pennington B (2000) Phenylketonuria. In: Yeates KO, Ris MD, Taylor HG (eds) Pediatric neuropsychology, 1st edn. The Guilford Press, New York, pp 275-299
33. M Williamson JC Dobson R Koch 1977 Collaborative study of children treated for Phenylketonuria: study design Pediatrics 60 815 821 (Pubitemid 8249264)
34. DA White MA Nortz T Mandernach K Huntington R Steiner 2002 Age-related working memory impairments in children with prefrontal dysfunction associated with phenylketonuria J Int Neuropsychol Soc 8 1 11 (Pubitemid 34130469)